发明名称 |
RISK ASSESSMENT FOR ANTIBOTICS TREATMENT IN PATIENTS SUFFERING FROM PRIMARY NON-INFECTIOUS DISEASE BY DETERMINING THE LEVEL OF PROCALCITONIN |
摘要 |
The present invention relates to a diagnostic method for the identification of a subject suffering from a primary non-infectious disease having an increased risk of an adverse outcome potentially being induced by the administration of an antibiotic to said subject comprising the determination of the level of Procalcitonin (PCT) or a fragment thereof or a precursor or fragment thereof having a length of at least 12 amino acid residues in a sample of a bodily fluid from said subject and the correlation of the determined level to a potential risk induced by the administration of an antibiotic.
|
申请公布号 |
US2012100635(A1) |
申请公布日期 |
2012.04.26 |
申请号 |
US201013264252 |
申请日期 |
2010.04.14 |
申请人 |
BERGMANN ANDREAS;STRUCK JOACHIM;B.R.A.H.M.S. GMBH |
发明人 |
BERGMANN ANDREAS;STRUCK JOACHIM |
分类号 |
G01N33/566;C07K16/18 |
主分类号 |
G01N33/566 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|